Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company ad...
Stay updated with breaking news from Stroke Conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company ad...
Researchers say Black women under the age of 35 who have high blood pressure have triple the risk of having a stroke
Irvine, Calif., Jan. 30, 2024 — Bernadette Boden-Albala, M.P.H., Dr.P.H., director of the University of California, Irvine Program in Public Health and foundi
DiaMedica Presents the Protocol and Rationale for ReMEDy2, a Pivotal Trial in Patients Suffering Acute Ischemic Stroke Ineligible for tPA and/or Mechanical Thrombectomy ...
The TENSION trial, which was stopped early for efficacy, selected patients using widely available non-contrast CT or CT angiography and should lead to more patients being considered for treatment.